Scenic Biotech BV, a pioneer in the discovery of genetic modifiers to enable the development of disease modifying therapeutics, has entered into a multi-year strategic collaboration with Genentech, a member of the Roche Group, to discover, develop and commercialize novel therapeutics that target genetic modifiers. Genetic modifiers are genes that counteract the effect of a disease-causing gene. Also known as disease suppressors, genetic modifiers can positively influence the severity of dise...